Austin Regional Clinic studying anti-flu drug in high-risk patients

Adjust Comment Print

As Americans suffer through the worst flu outbreak in nearly a decade, a Japanese drug maker says it has developed a pill that can kill the virus in one day.

Shinogai's CEO Isao Teshirogi said the compound works by blocking the flu from hijacking other cells in the body, thus keeping it from spreading.

An experimental drug could soon provide relief during flu season. The Food and Drug Administration also mentions this as a potential, saying that people who have the flu or take Tamiflu should be watched for signs of unusual behavior.

Once inside a cell, it captures the cell's apparatus, driving the cell to make duplicates of the infection.

"Since we're not using the brand name anymore, and the price has come down, there isn't a coupon available to decrease that copay", she said.

The drug is on the fast-track to approval in Japan and could be approved there as early as March, the WSJ said. The drug's creators said they will apply for USA approval this summer but a decision probably wouldn't be made until next year.

Uttar Pradesh: Bus torched in Allahabad to protest against law student's murder
The main accused, Munna Chauhan, was arrested after being identified from the CCTV footage obtained from the restaurant. They are later seen hoisting the boy's lifeless body on a bike and taking him to the hospital.

But this year, the flu really is just awful. "We may be on track to break some recent records".

Beyond vaccination, there's a handy shortlist of things to know about the flu for this year, and a number of evidence-based things you can do to help avoid the worst of the flu (and to beat colds too) - including some things you might not exactly expect.

While we all wait for the long-anticipated universal flu vaccine to arrive, the regular flu vaccination is still your best bet at the outset of any flu season.

Getting vaccinated is still the best defence against the flu. It is highly contagious and generally spreads from person-to-person when an infected person coughs or sneezes, Hill said.

Still, those who have underlying conditions stand a greater risk from the flu than they do the antidote to it, Peak said.